Page last updated: 2024-10-24

negative regulation of lymphocyte proliferation

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the rate or extent of lymphocyte proliferation. [GOC:ai]

Negative regulation of lymphocyte proliferation is a crucial process that ensures immune homeostasis and prevents uncontrolled immune responses, potentially leading to autoimmune diseases. This complex process involves a tightly regulated network of signaling pathways, transcription factors, and effector molecules that act in concert to suppress lymphocyte activation and proliferation. Key mechanisms involved in negative regulation of lymphocyte proliferation include:

1. **Inhibition of TCR signaling:** The T cell receptor (TCR) is the primary receptor responsible for triggering T cell activation and proliferation. Several mechanisms exist to inhibit TCR signaling, including:
- **Negative costimulatory molecules:** Molecules such as CTLA-4 and PD-1 engage with their ligands on antigen-presenting cells, delivering inhibitory signals that dampen TCR signaling.
- **Phosphatases:** Enzymes like SHP-1 and SHP-2 dephosphorylate key signaling molecules downstream of the TCR, thereby attenuating the signaling cascade.
- **Adaptor proteins:** Proteins like Cbl-b and Grb2 can act as negative regulators by promoting the degradation of signaling molecules or by interfering with their interactions.

2. **Induction of anergy:** Anergy is a state of unresponsiveness to specific antigens. It can be induced by weak or prolonged TCR stimulation in the absence of costimulatory signals. Anergy is characterized by downregulation of TCR signaling components and increased expression of inhibitory molecules.

3. **Cytokine-mediated suppression:** Several cytokines, such as IL-10, TGF-β, and IL-35, have immunosuppressive properties. They can suppress lymphocyte proliferation by inducing the expression of inhibitory molecules, promoting T cell exhaustion, or skewing differentiation towards regulatory T cells (Tregs).

4. **Regulatory T cell (Treg) activity:** Tregs are a specialized subset of T cells that play a crucial role in maintaining immune tolerance. They suppress the activity of other lymphocytes through various mechanisms, including:
- **Production of suppressive cytokines:** Tregs secrete IL-10 and TGF-β, which inhibit the proliferation and effector function of other T cells.
- **Direct cell-cell interactions:** Tregs can directly interact with other lymphocytes through the expression of CTLA-4 and other inhibitory molecules.

5. **Induction of apoptosis:** When lymphocytes receive strong or prolonged stimulation, they can undergo apoptosis, a programmed cell death process that eliminates potentially harmful cells. Apoptosis is triggered by various mechanisms, including the activation of caspases and the release of pro-apoptotic proteins from the mitochondria.

In summary, negative regulation of lymphocyte proliferation is a multifaceted process involving a diverse array of inhibitory mechanisms. This intricate network of regulatory pathways ensures that immune responses are tightly controlled, preventing uncontrolled lymphocyte activation and potential autoimmune pathology.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Interleukin-2An interleukin-2 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P60568]Homo sapiens (human)

Compounds (7)

CompoundDefinitionClassesRoles
daidzindaidzein 7-O-beta-D-glucoside : A glycosyloxyisoflavone that is daidzein attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It is used in the treatment of alcohol dependency (antidipsotropic).

daidzin: a potent, selective, and reversible inhibitor of human mitochondrial aldehyde dehydrogenase
7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative
plant metabolite
ononin4'-methoxyisoflavones;
7-hydroxyisoflavones 7-O-beta-D-glucoside;
monosaccharide derivative
plant metabolite
formononetin4'-methoxyisoflavones;
7-hydroxyisoflavones
phytoestrogen;
plant metabolite
luteolin-7-glucosideluteolin 7-O-beta-D-glucoside : A glycosyloxyflavone that is luteolin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.

luteolin-7-glucoside: has both antiasthmatic and antineoplastic activities; has 3C protease inhibitory activity; isolated from Ligustrum lucidum
beta-D-glucoside;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
antioxidant;
plant metabolite
N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamideN(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide : A leucine derivative obtained by fpormal condensation of the secondary amino group of 5-({2,3-dichloro-4-[1-methyl-5-(piperidin-4-yl)-1H-pyrazol-3-yl]phenoxy}methyl)-2-furoic acid and the carboxy group of N-amidino-L-leucylglycineD-leucine derivative;
dichlorobenzene;
furoic acid;
glycine derivative;
guanidines;
pyrazolylpiperidine
calycosin-7-o-beta-d-glucopyranosidecalycosin-7-O-beta-D-glucoside : A glycosyloxyisoflavone that is calycosin substituted by a beta-D-glucopyranosyl residue at position at 7 via a glycosidic linkage.

calycosin-7-O-beta-D-glucoside: from Radix Astragali
4'-methoxyisoflavones;
7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative
diosgenin glucosidediosgenin 3-O-beta-D-glucoside : A sterol 3-beta-D-glucoside having diosgenin as the sterol component.

diosgenin glucoside: RN given refers to (3beta,25R)-isomer; structure given in first source
hexacyclic triterpenoid;
monosaccharide derivative;
spiroketal;
sterol 3-beta-D-glucoside
metabolite